Bio-thera Solutions, Ltd. Class ASSE: 688177

Announcement on Obtaining Acceptance of Application for Marketing Authorization of Golimumab Injection (BAT2506)

· Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Acceptance of Application for Marketing Authorization of Golimumab Injection (BAT2506)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis